In Recent Guidance, FDA aims for Patient Safety at 503B Facilities
The FDA has issued a guidance to 503B facilities regarding Current Good Manufacturing Practice (gCMB)
FDA Issues Guidance on Verification Systems
The FDA recently issued a draft guidance regarding verification* systems in accordance with the Drug Supply Chain Security Act (DSCSA).
ConsortiEX ASHP Midyear Recap, Prioritizing Patient Safety
We want to thank everybody who came to visit our booth at this year’s ASHP Midyear Clinical Meeting & Exhibition. We always appreciate the opportunity to show off our products to the people who need them most.
Control Patient Safety with Assure-Trak® IV Workflow Management
At ConsortiEX, we work diligently to create solutions designed specifically for the unique needs of health system pharmacies. The result is our Assure-Trak® IV Workflow Management Dynamic Patient Specific Compounding application a dynamically configurable IV Workflow solution to enhance patient safety and optimize[...]
Take Control of Patient Safety and Quality Control with InsightRX
Just last week, ConsortiEX proudly announced our new InsightRX Passive Audit Monitoring module.
Be Compliant with Confidence, DSCSA Compliance as a Service
Understanding the rules and regulations behind DSCSA Compliance can be a daunting task. As deadlines pass, the FDA regularly updates what it means to be compliant. ConsortiEX is proud to offer DSCSA Compliance as a Service (CaaS). Our CaaS module removes the burden of being compliant from the dispenser community with[...]
Address Quality Control, Re-insourcing CSP Production with a Central Fill Model
Today, cost and quality issues surrounding compounded sterile preparations (CSP’s) have nearly every major health system investigating what it takes to re-insource production. Most are looking at a hub and spoke approach, where their central-fill Batch Compounding can support the CSP production needs of all the[...]
Come see what You've been Missing, ConsortiEX is Attending ASHP Midyear
ConsortiEX is proudly attending ASHP Midyear. Stop by Booth 900 to see how our intuitive Pharmacy-Focused ERP solutions can enhance your patient safety, ensure quality control, and simplify compliance, first-hand and in-person. Our new InsightRX Passive Audit Monitoring hood will be on display.
InsightRX Passive Audit Monitoring: See What Others Miss
Introducing InsightRX Passive Audit Monitoring: See what others miss.
Recent FDA Guidance Sparks Concerns from Industry Leaders
Several key industry players have issued responses to the FDA in regard to the recent draft guidance on the use of Product Identifiers, and the policy on grandfathered product, in compliance with the Drug Supply Chain Security Act (DSCSA).